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Abstract Alternative splicing (AS) programs are primarily controlled by regulatory RNA-binding
proteins (RBPs). It has been proposed that a small number of master splicing regulators might
control cell-specific splicing networks and that these RBPs could be identified by proximity of their
genes to transcriptional super-enhancers. Using this approach we identified RBPMS as a critical
splicing regulator in differentiated vascular smooth muscle cells (SMCs). RBPMS is highly down-
regulated during phenotypic switching of SMCs from a contractile to a motile and proliferative
phenotype and is responsible for 20% of the AS changes during this transition. RBPMS directly
regulates AS of numerous components of the actin cytoskeleton and focal adhesion machineries
whose activity is critical for SMC function in both phenotypes. RBPMS also regulates splicing of
other splicing, post-transcriptional and transcription regulators including the key SMC transcription
factor Myocardin, thereby matching many of the criteria of a master regulator of AS in SMCs.
DOI: https://doi.org/10.7554/eLife.46327.001
Introduction
Alternative splicing (AS) is an important component of regulated gene expression programmes dur-
ing cell development and differentiation, usually focusing on different sets of genes than transcrip-
tional control (Blencowe, 2006). AS programs re-wire protein-protein interaction networks
(Buljan et al., 2012; Ellis et al., 2012; Yang et al., 2016), as well as allowing quantitative regulation
by generating mRNA isoforms that are differentially regulated by translation or mRNA decay
(McGlincy and Smith, 2008; Mockenhaupt and Makeyev, 2015). Coordinated cell-specific splicing
programs are determined by a combination of cis-acting transcript features and trans-acting factors
that compose ‘splicing codes’ (Barash et al., 2010; Chen and Manley, 2009; Fu and Ares, 2014).
The interactions between the trans component RNA-binding proteins (RBPs) and the cis component
regulatory elements in target RNAs coordinate the activation and repression of specific splicing
events. Many regulatory proteins, including members of the SR and hnRNP protein families, are
quite widely expressed, while others are expressed in a narrower range of cell types (David and
Manley, 2008; Fu and Ares, 2014). A further conceptual development of combinatorial models for
splicing regulation has been the suggestion that a subset of RBPs act as master regulators of cell-
type specific AS networks (Jangi and Sharp, 2014). The criteria expected of such master regulators
include that: (i) they are essential for cell-type specification or maintenance, (ii) their direct and indi-
rect targets are important for cell-type function, (iii) they are likely to regulate the activity of other
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splicing regulators, (iv) they exhibit a wide dynamic range of activity, which is not limited by autore-
gulation, and (v) they are regulated externally from the splicing network, for example by transcrip-
tional control or post-translational modifications. It was further suggested that expression of such
splicing master regulators would be driven by transcriptional super-enhancers, providing a possible
route to their identification (Jangi and Sharp, 2014). Super-enhancers are extended clusters of
enhancers that are more cell-type-specific than classical enhancers and that drive expression of
genes that are essential for cell-type identity, including key transcription factors (Hnisz et al., 2013).
By extension, RBPs whose expression is driven by super-enhancers are expected to be critical for
cell-type identity and might include master regulators of tissue-specific AS networks (Jangi and
Sharp, 2014).
Vascular smooth muscle cells (SMCs) are important in cardiovascular physiology and pathology
(Bennett et al., 2016; Fisher, 2010; Owens et al., 2004). Unlike skeletal and cardiac muscle SMCs
exhibit phenotypic plasticity and are not terminally differentiated (Owens et al., 2004) (Figure 1A).
In healthy arteries, vascular SMCs exist in a differentiated contractile state. In response to injury or
disease, the SMC phenotype switches towards a more synthetically active, motile and proliferative
state (Fisher, 2010; Owens et al., 2004). The transcriptional control of SMC phenotypic switching
has been intensely studied, but the role of post-transcriptional regulation has been relatively
neglected (Fisher, 2010). For example, some markers of the contractile state, such as h-Caldesmon
and meta-Vinculin, arise via AS (Owens et al., 2004), but nothing is known about the regulation of
these events. A number of known splicing regulators, including PTBP1, CELF, MBNL, QKI, TRA2B,
and SRSF1, have been implicated in the regulation of individual SMC-specific ASEs, but these pro-
teins are not restricted to differentiated SMCs and most act primarily in the de-differentiated state
(Gooding et al., 2013; Gooding et al., 1998; Gromak et al., 2003; Shukla and Fisher, 2008;
van der Veer et al., 2013; Xie et al., 2017). Indeed, global profiling confirmed a widespread role of
PTBP1 in repressing exons that are used in differentiated mouse aorta SMCs (Llorian et al., 2016),
but did not identify RBPs that act as direct regulators of the differentiated state. Biochemical
eLife digest All the cells in our body contain the same genetic information, but they only switch
on the genes that they need to fulfill their specific role in the organism. Genetic sequences known as
enhancers can turn on the genes that are required by a particular cell to perform its tasks.
Once a gene is activated, its sequence is faithfully copied into a molecule of RNA which contains
segments that code for a protein. A molecular machine then processes the RNA molecule and
splices together the coding segments. RNA binding proteins can also regulate this mechanism, and
help to splice the coding sections in different ways depending on the type of cell. The process,
known as alternative RNA splicing, therefore creates different RNA templates from the same gene.
This gives rise to related but different proteins, each suited to the needs of the particular cell in
which they are made.
However, in some cell types, exactly how this happens has not yet been well documented. For
example, in cells that line blood vessels – known as vascular smooth muscle cells – the RNA binding
proteins that drive alternative splicing have not been identified.
To find these proteins, Nakagaki-Silva et al. used catalogs of DNA regions called super-enhancers
as clues. These sequences strongly activate certain genes in a tissue-specific manner, effectively
acting as labels for genes important for a given cell type. In vascular smooth muscle cells, if a super-
enhancer switches on a gene that codes for a RNA-binding protein, this protein is probably crucial
for the cell to work properly.
The approach highlighted a protein called RBPMS, and showed that it controlled alternative RNA
splicing of many genes important in smooth muscle cells. This may suggest that when RBPMS
regulation is disrupted, certain diseases of the heart and blood vessels could emerge. Finally, the
results by Nakagaki-Silva et al. demonstrate that super-enhancers can signpost genes important in
regulating splicing or other key processes in particular cell types.
DOI: https://doi.org/10.7554/eLife.46327.002
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identification of such RBPs is hampered by the fact that SMCs rapidly dedifferentiate in cell culture
conditions.
Here, we used the approach suggested by Jangi and Sharp, to identify candidate AS master reg-
ulators as RBP-encoding genes whose cell-specific expression is driven by super-enhancers
(Jangi and Sharp, 2014). We identified RNA-Binding Protein with Multiple Splicing (RBPMS), a pro-
tein not previously known to regulate splicing, as a critical regulator of numerous AS events in
SMCs. RBPMS is highly expressed in differentiated SMCs, where it promotes AS of genes that are
important for SMC function. These include many components of the actin cytoskeleton and focal
adhesion machineries, modulation of whose function is key to the transition from contractile to
motile phenotypes. RBPMS also targets other splicing regulators, post-transcriptional regulators and
the key SMC transcription factor Myocardin where RBPMS promotes inclusion of an exon that is
essential for maximal SMC-specific activity. RBPMS therefore meets many of the criteria expected of
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Figure 1. RBPMS is associated with SMC super-enhancers and is highly expressed in the differentiated PAC1 cells. (A) Diagram of the SMC
dedifferentiation. SMC markers of differentiation and dedifferentiation are respectively shown at the bottom and top of the diagram. (B) Venn diagram
of RBP genes associated with super-enhancers across different human smooth muscle tissues. Skeletal muscle was used as an outlier. RBPs common to
all smooth muscle tissues but not skeletal muscle are shown on the left. (C) Schematic of the AS event determining the two major RBPMS isoforms,
RBPMS A (red) and RBPMS B (yellow). (D) RT-PCR analysis of SMC splicing markers, Actn1 and Tpm1, in differentiated (D) and proliferative (P) PAC1
cells. Schematic of the regulated mutually exclusive splicing events on top and respective isoforms products on the left. Values shown are the
quantified PSI (percent spliced in) of the smooth muscle isoforms (SM) ± standard deviation (n = 3). (E) qRT-PCR analysis of Rbpms (all isoforms),
Rbpms2 and SMC differentiation markers Acta2, Cnn1 and Smtn, in PAC1 cells D (green) and P (blue). Expression was normalized to the average of two
housekeepers (Gapdh and Rpl32) and the mean of the relative expression is shown (n = 3). Each point shows data from an individual sample. Statistical
significance was performed using Student’s t-test (*p<0.05, **p<0.01, ***p<0.001). (F) Western blots for RBPMS in D and P PAC1 cells. ACTA2 is a SMC
differentiation marker and GAPDH a loading control. A and B indicates the two RBPMS isoforms. (G) Immunofluorescence in D and P PAC1 cells for
RBPMS. DAPI staining for nuclei.
DOI: https://doi.org/10.7554/eLife.46327.003
The following figure supplements are available for figure 1:
Figure supplement 1. RBPMS is highly expressed in SM tissues.
DOI: https://doi.org/10.7554/eLife.46327.004
Figure supplement 2. mRNA abundance analysis of the rat aorta SMC de-differentiation RNA-Seq.
DOI: https://doi.org/10.7554/eLife.46327.005
Figure supplement 3. Alternative splicing analysis of the rat aorta SMC de-differentiation RNA-Seq.
DOI: https://doi.org/10.7554/eLife.46327.006
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an AS master regulator in SMCs, and its identification validates the approach of identifying key cell-
specific regulators via the super-enhancer-proximity of their genes.
Results
RBPMS is a SMC splicing regulator
To identify potential SMC master splicing factors we used a catalog of 1542 human RBPs
(Gerstberger et al., 2014) and data-sets of super-enhancers from three human SMC-rich tissues
(aorta, bladder, stomach smooth muscle) and skeletal muscle (Hnisz et al.,
2013) (Supplementary file 1). Nine RBP genes were associated with super-enhancers in all SMC tis-
sues but not skeletal muscle (Figure 1B). Using the dbSUPER database (Khan and Zhang, 2016),
which uses more stringent distance constraints for associating genes with superenhancers (see Mate-
rials and methods), we identified two candidates, of which only RBPMS was shared with our original
nine candidates. Examination of RBPMS expression in human tissues from the Genotype-Tissue
Expression (GTEX) project (GTEx Consortium, 2013) showed the top eight expressing tissues to be
SMC rich, including three arteries (Figure 1—figure supplement 1A). RNA-Seq data from rat aorta
SMCs showed that Rbpms levels decreased 3.8 fold during de-differentiation from tissue to passage
9 cell culture (Figure 1—figure supplement 1A–C), in parallel with known SMC transcriptional
markers (Acta2, Cnn1, Smtn, (Figure 1—figure supplement 1B,C) and AS events (Tpm1 and Actn1,
Figure 1—figure supplement 3A,C). Moreover, of the starting candidate RBPs (Figure 1B) Rbpms
was the most highly expressed of those that were down-regulated from tissue to culture (Figure 1—
figure supplement 2B,C green labels). Expression of the Rbpms2 paralog also decreased upon de-
differentiation, but its absolute level of expression was >10 fold lower than Rbpms (Figure 1—figure
supplement 2B,C). Other RBPs implicated in AS regulation in SMCs (PTBP1, MBNL1, QKI) either
showed more modest changes or higher expression in de-differentiated cells (Figure 1—figure sup-
plement 2B,C). In the PAC1 rat SMC line Rbpms mRNA levels decreased by ~10 fold between dif-
ferentiated and proliferative states in parallel with SMC marker AS events (Figure 1D) and genes
(Figure 1E). Rbpms2 was expressed at much lower levels than Rbpms, and did not alter expression
between PAC1 cell states (Figure 1E). RBPMS protein decreased to undetectable levels in prolifer-
ative PAC1 cells in parallel with smooth muscle actin (ACTA2) (Figure 1F). Immunofluorescence
microscopy also showed higher levels of RBPMS in differentiated PAC1 cells where it was predomi-
nantly nuclear (Figure 1G), consistent with the hypothesis that it regulates splicing.
To further investigate RBPMS expression we cloned cDNAs from PAC1 cells, representing seven
distinct mRNA isoforms. These encoded two major protein isoforms (RBPMSA and RBPMSB) sharing
a common N-terminus and RNA Recognition Motif (RRM) domain. RBPMSA and B differed by short
C-terminal tails encoded by alternative 3’ end exon 7 and exon 8 (Figure 1C), and corresponded in
size to the two protein bands seen in western blots (Figure 1F). Other mRNA isoforms differed by
inclusion or skipping of exon six and by alternative 3’ UTR exon inclusion. RBPMS and RBPMS2,
which are 70% identical, have a single RRM domain that is responsible for both RNA binding and
dimerization (Sagnol et al., 2014; Teplova et al., 2016). Optimal RBPMS -binding sites consist of
tandem CACs separated by a spacer of ~1–12 nt (Farazi et al., 2014; Soufari and Mackereth,
2017). We found significant enrichment of CACN1-12CAC motifs within and upstream of exons that
are less included in differentiated compared to cultured rat aorta SMCs (Figure 1—figure supple-
ment 3D). These are locations at which many splicing regulators mediate exon skipping (Fu and
Ares, 2014; Witten and Ule, 2011). Consistent with this, the SMC-specific mutually exclusive exon
pairs in Actn1 and Tpm1 (Gooding and Smith, 2008; Southby et al., 1999) both have conserved
clusters of CAC motifs upstream of the exon that is skipped in differentiated SMCs (see below).
In summary, the presence of super-enhancers at the RBPMS gene in SMC-rich tissues, its wide
dynamic range of expression between differentiated SMCs and other tissues and proliferative SMCs
(Figure 1, Figure 1—figure supplements 1–3), the nuclear localization of RBPMS, and the presence
of potential RBPMS-binding sites adjacent to known SMC-regulated exons are all consistent with the
hypothesis that RBPMS might act as a master regulator of AS in differentiated SMCs.
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RBPMS promotes a differentiated SMC splicing program
To investigate the roles of RBPMS in shaping SMC transcriptomes we manipulated levels of RBPMS
expression in differentiated and proliferative PAC1 cells (Figure 2A,B). We used siRNAs to knock-
down all Rbpms isoforms in differentiated PAC1 cells, achieving ~75% depletion (Figure 2B). In par-
allel, proliferative PAC1 cells were transduced with pINDUCER lentiviral vectors (Meerbrey et al.,
2011) to allow Doxycycline inducible over-expression of RBPMSA. No basal RBPMS expression was
observed in proliferative cells, but upon induction substantial expression was observed from the
FLAG-RBPMSA vector but not from the empty lentiviral vector (LV) (Figure 2B). The effects of
manipulating RBP levels can sometimes be compensated by related family members
(Mockenhaupt and Makeyev, 2015). However, Rbpms2 levels were not affected by any of the treat-
ments and Rbpms2 knockdown, either alone or in combination with Rbpms, had no effects upon
tested AS events (data not shown).
RNA samples from Rbpms knockdown and overexpression experiments were prepared for Illu-
mina poly(A) RNAseq. Data was analyzed for changes in mRNA abundance using DESEq2
(Love et al., 2014) (Figure 2C, Supplementary file 2), and for changes in AS using rMATS
(Shen et al., 2014) (Figure 2D, Supplementary file 3). In addition to analysis of effects of RBPMS
depletion and overexpression, comparison of the differentiated and proliferative PAC1 control sam-
ples revealed changes associated with differentiation state. Principal Component Analysis based on
mRNA abundance showed clear separation of differentiated and proliferative samples (PC1, 82%
variance, Figure 2—figure supplement 1A). This suggests that at the level of mRNA abundance the
differences between differentiated and proliferative PAC1 cells far outweigh any effects of manipu-
lating RBPMS levels. Consistent with this, RBPMS knockdown was associated with ~10 fold fewer
changes at the transcript abundance level (110 increased, 82 decreased, padj <0.05, fold change >2
fold) compared to the differentiated vs proliferative control comparison (830 increased, 1444
decreased, Figure 2C). RBPMS overexpression led to an intermediate number of changes in mRNA
abundance levels, but only 29 genes were affected by both overexpression and knockdown, and of
these only four genes other than Rbpms were regulated reciprocally.
RBPMS knockdown and overexpression had substantial effects at the level of AS affecting all
types of AS event (Figure 2D, Figure 2—figure supplement 1B). RBPMS knockdown led to changes
in 318 AS events (FDR < 0.05, |DPSI| > 0.1, where PSI is Percent Spliced In), which was only 2-fold
less than the number of events regulated between control differentiated and proliferative cells. Cas-
sette exons were the largest group of events, with roughly equal numbers of up- and down-regu-
lated exons (Figure 2D). RBPMS overexpression led to a larger number of AS changes (4934
regulated events), probably resulting from the combination of RBPMS expression in excess of levels
usually present in differentiated PAC1 cells (Figure 2C) and also because we expressed the more
active RBPMSA isoform (see below). Cassette exons affected by RBPMS overexpression were
strongly skewed (80%) towards greater exon skipping. A subset of ASEs observed in the RNA-Seq
experiments, encompassing RBPMS activated and repressed cassette exons and mutually exclusive
exons were validated by RT-PCR (Figure 2E,F, Figure 2—figure supplements 2 and 3). DPSI values
determined by RT-PCR and RNA-Seq were in good agreement (Figure 2—figure supplement 3B).
As an additional negative control, doxycycline induction of empty lentiviral transduced cells had no
effect on RBPMS-regulated AS events (Figure 2—figure supplement 2A).
In each of the three comparisons, the overlap between genes regulated at the levels of splicing
and mRNA abundance was small: 0.8% of all genes regulated at splicing or abundance level for
RBPMS knockdown, 3.2% for RBPMS overexpression, and 1.6% for PAC1 phenotype, (Figure 2—fig-
ure supplement 1C). However, there were substantial overlaps of ASEs regulated by RBPMS knock-
down, overexpression and PAC1 phenotype (Figure 3A). Twenty percent of ASEs regulated in PAC1
cell differentiation were congruently regulated by RBPMS knockdown, representing 40% of ASEs
affected by RBPMS knockdown (Figure 3A and B left panel). The high correlation (R2 = 0.95) sug-
gests that for these 127 events changes in RBPMS expression are sufficient to explain their differenti-
ation-specific splicing changes. Similarly, RBPMS overexpression shared 180 events in common with
PAC1 differentiation status (28% of differentiation specific events, 3.7% of overexpression regulated
events). The DPSI correlation for these AS events was lower than for RBPMS knockdown (R2 = 0.86,
Figure 3A and B right panel). Sixty seven events regulated by RBPMS knockdown were reciprocally
regulated by RBPMS overexpression, of which 52 were shared across all the three comparisons
Nakagaki-Silva et al. eLife 2019;8:e46327. DOI: https://doi.org/10.7554/eLife.46327 5 of 33
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Figure 2. RBPMS regulates AS in PAC1 cells. (A) Schematic of experimental design of RBPMS knockdown and overexpression in PAC1 cells. (B)
Western blots for RBPMS in PAC1 knockdown, left, and inducible lentiviral overexpression, right. FLAG antibodies were also used for the
overexpression of 3xFLAG tagged RBPMS. GAPDH and TUBULIN were used as loading controls. (C) MA plots of alterations in mRNA abundance in
PAC1 dedifferentiation, left, RBPMS knockdown, middle, and RBPMS A overexpression, right. Dark gray: genes with significant changes (p-adj <0.05).
Figure 2 continued on next page
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(8.2% of differentiation specific events), as exemplified by events in Ptprf, Piezo1 and Actn1
(Figure 2E). Hierarchical clustering of cassette exons regulated between PAC1 phenotypes across all
12 samples also revealed two clusters of RBPMS-responsive events where knockdown and overex-
pression were sufficient to reciprocally convert the splicing pattern to that of the other cellular phe-
notype (Figure 3E, clusters 1 and 4, containing RBPMS activated and repressed exons respectively).
Many AS events in differentiated PAC1 cells do not reach the fully differentiated splicing pattern
characteristic of tissue SMCs. However, for some events overexpression of RBPMS led to splicing
patterns similar to tissue SMCs. For example the Actn1 SM exon is included to 69% in differentiated
PAC1 cells, but to 93–94% in RBPMS overexpressing cells (Figure 2E) and aorta tissue (Figure 1—
figure supplement 3C). We therefore hypothesized that some ASEs regulated by RBPMS overex-
pression but not knockdown, might reflect tissue SMC AS patterns that are not usually observed in
cultured SMCs. To address this possibility, we used RNA-Seq data monitoring de-differentiation of
rat aorta SMCs (Figure 1—figure supplements 2 and 3). Of 1714 ASES regulated between tissue
and passage 9 SMCs, 265 (15%) were also regulated by RBPMS overexpression in PAC1 cells
(Figure 3C,D, R2 = 0.68). Strikingly, hierarchical clustering of cassette exons regulated between
aorta tissue and passage nine cultured SMCs showed that the RBPMS overexpression sample clus-
tered together with tissue, away from all other samples (Figure 3F). Two clusters of AS events
shared very similar splicing patterns in tissue and RBPMSA overexpression, and differed in all
remaining samples (Figure 3F). Cluster 1 comprised 28 RBPMS-activated exons, of which 20 were
not regulated between PAC1 phenotypes. For example, inclusion of a cassette exon in Fermt2 was
observed only in tissue and RBPMS overexpression samples (Figure 3G). Similarly, inclusion of Cald1
exon four in conjunction with a downstream 5’ splice site on exon 3a, producing the hCald1 marker
in tissue SMCs (Figure 3G, Figure 3—figure supplement 1C,D), and inclusion of the meta-vinculin
exon (Figure 3—figure supplement 1A) were also only seen upon RBPMS overexpression. Cluster
four contained exons that are skipped in tissue and upon RBPMS overexpression (e.g. Tsc2,
Figure 3G), the majority of which are not regulated in PAC1 differentiated cells. Likewise Tpm1
mutually exclusive exon three is skipped nearly completely upon RBPMS overexpression in a similar
pattern to tissue (Figure 3—figure supplement 1B). Upregulation of RBPMS expression therefore
appears to be sufficient to promote a subset of splicing patterns usually only observed in differenti-
ated SMCs in vivo.
RBPMS directly regulates exons with associated CAC motifs
To address whether RBPMS directly regulates target exons we looked for enrichment of its binding
motif (Farazi et al., 2014) adjacent to cassette exons regulated by RBPMS knockdown or
Figure 2 continued
Light gray: genes with p-adj 0.05. Red: Rbpms, Rbpms2 and the SMC marker, Acta2. Numbers of up and down-regulated are shown at top and
bottom. Horizontal lines; log2 fold change = 1 and  1. (D) AS changes (FDR < 0.05 and DPSI greater than 10%) in PAC1 cell dedifferentiation, left,
RBPMS knockdown, middle, and RBPMS A overexpression, right. ASE were classified into skipped exon (SE), mutually exclusive exon (MXE), alternative
50 and 30 splice site (A5SS and A3SS) and retained intron (RI) by rMATS. Numbers indicate the number of significant ASE of each event type between
the conditions compared. (E) Sashimi plots of selected ASEs. Ptprf is shown as a differentiated cassette exon (green), Piezo1 as a proliferative cassette
exons (blue) and Actn1 as a MXE. The numbers on the arches indicate the number of reads mapping to the exon-exon junctions. PSI values for the ASE
are indicated for each condition. Values correspond to the mean PSI calculated by rMATS. In the case of the Actn1 MXE, the percent inclusion of the
SM exon is shown (PSI-SM). Schematic of the mRNA isoforms generated by the alternative splicing are found at the bottom as well as the chromosome
coordinates. (F) RT-PCR validation of ASEs from panel E. Values shown are the mean of the PSI ± standard deviation (n = 3). Statistical significance was
calculated using Student’s t-test (*p<0.05, **p<0.01, ***p<0.001). See Figure 2—figure supplement 3 for more ASEs validated in the RBPMS
knockdown and RBPMS A overexpression by RT-PCR.
DOI: https://doi.org/10.7554/eLife.46327.007
The following figure supplements are available for figure 2:
Figure supplement 1. Principal Component Analysis of PAC1 RNAseq samples and overlap of genes regulated at the splicing and abundance levels.
DOI: https://doi.org/10.7554/eLife.46327.008
Figure supplement 2. AS changes of SM genes are specific to RBPMS expression.
DOI: https://doi.org/10.7554/eLife.46327.009
Figure supplement 3. DPSI values determined by RT-PCR and RNA-Seq show good agreement.
DOI: https://doi.org/10.7554/eLife.46327.010
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Figure 3. RBPMS recapitulates the AS program of differentiated PAC1 and aorta tissue. (A) Venn diagram of significant ASEs (FDR < 0.05 and DPSI
cutoff of 10%) identified in the PAC1 dedifferentiation, RBPMS knockdown and RBPMS A overexpression comparisons. (B) DPSI correlation of
overlapping ASEs (FDR < 0.05 and DPSI cutoff of 10%) from the PAC1 cells dedifferentiation and RBPMS knockdown, left, or RBPMS A overexpression,
right. The line indicates the linear regression model. Statistical significance was carried out by Pearson correlation test. n is the number of ASEs
Figure 3 continued on next page
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overexpression. CACN1-12CAC motifs, the optimal binding motif for RBPMS dimers, were signifi-
cantly enriched around exons that were activated or repressed by RBPMS, with a similar position-
dependent activity as other splicing regulators (Figure 4A). Exons repressed by RBPMS showed
strong enrichment of motifs within the exon and the immediate ~80 nt upstream intron flank, while
exons activated by RBPMS showed motif enrichment within the downstream intron flank. Consistent
with the contribution of RBPMS to the AS changes between PAC1 differentiation states, CACN1-
12CAC motifs were also enriched upstream of and within exons that are more skipped in differenti-
ated cells, and downstream of exons that are more included in differentiated cells (Figure 4A).
Moreover, in the set of exons activated by RBPMS overexpression, CACN1-12CAC motifs were not
only enriched downstream, but also significantly depleted in the repressive locations within and
upstream of the exon (Figure 4A,B). This suggests that binding in repressive locations might be
dominant over activation.
To test whether RBPMS regulates AS events by directly binding to CAC motifs we co-transfected
HEK293 cells with RBPMS expression vectors and minigenes of representative activated (Flnb) and
repressed (Tpm1, Actn1) exons, with potential RBPMS-binding sites in expected locations for activa-
tion or repression (Figure 4—figure supplements 1B–C and 2B). We initially established that tran-
sient expression of RBPMSA in HEK293 cells was sufficient to switch AS of endogenous FLNB,
TPM1, MPRIP and ACTN1 towards the SMC splicing pattern (Figure 4C,G and Figure 4—figure
supplement 1A). For comparison, we also transfected expression constructs for the RBPMSB iso-
form and the paralog RBPMS2. We found that RBPMSB had lower activity for some events (ACTN1,
Figure 4—figure supplement 1A), but that transfected RBPMS2 had similar activity to RBPMSA in
all cases. RBPMSA and RBPMS2 also strongly activated inclusion of the Flnb H1 exon in a minigene
context while RBPMSB activated to a lower extent (Figure 4D). Tpm1 exon three is the regulated
member of a pair of mutually exclusive exons and is repressed in SMCs (Ellis et al., 2004;
Gooding et al., 1994). MBNL and PTBP proteins promote this repression but are not sufficient to
switch splicing (Gooding et al., 2013; Gooding et al., 1998). In contrast, RBPMSA expression was
sufficient to cause a near complete switch from exon inclusion to skipping (Figure 4H). RBPMS2 had
lower activity, but RBPMSB was by far the least active protein. Likewise, RBPMSA and RBPMS2
completely switched splicing of Actn1 constructs (Gromak et al., 2003; Southby et al., 1999) from
the NM to the SM mutually exclusive exon, while RBPMSB was nearly inactive (Figure 4—figure sup-
plement 2A). A construct containing only the Actn1 SM exon was unresponsive to cotransfection,
while a construct containing only the NM exon, which has three upstream CAC clusters (Figure 4—
figure supplement 1B) showed a complete switch from inclusion to skipping upon cotransfection of
RBPMSA or RBPMS2, but not RBPMSB. Thus, for two mutually exclusive events RBPMSA is able to
switch splicing to the SMC pattern by repressing the exon that is usually used in non-SMCs, while
RBPMSB is less active.
Figure 3 continued
assessed, r2 is the correlation coefficient. Statistical significance of the correlation: *p<0.05, **p<0.01, ***p<0.001. (C) Venn diagram of significant ASEs
identified in RBPMS knockdown, overexpression and aorta tissue to passage nine comparisons. (D) DPSI correlation of overlapping ASEs from the rat
aorta tissue dedifferentiation and RBPMS knockdown, left, or RBPMS A overexpression, right. (E) Heatmap of 289 SEs regulated in the PAC1
dedifferentiation comparison (D Ctr - P Ctr). Each column represents a replicate sample (1-3) from RBPMS knockdown (D Ctr and D KD) or
overexpression (P Ctr and P OE). Rows are significant SE events from PAC1 dedifferentiation. Rows and columns were grouped by hierarchical
clustering. Blue and green colors in the Z-score scaled rows represent low and high PSI values respectively. (F) Heatmap of 590 SEs regulated in the rat
aorta tissue dedifferentiation comparison (T - P9). Each column represents one sample from either aorta tissue dedifferentiation (T and P9), RBPMS
knockdown (D Ctr and D KD) or RBPMS overexpression (P Ctr and P OE). Rows are significant SE events from the T - P9 comparison. Rows and columns
were grouped by hierarchical clustering. Blue and green colors in the Z-score scaled rows represent low and high PSI values respectively. (G) Sashimi
plots of selected ASEs highly regulated in the aorta tissue and RBPMS overexpression. Fermt2 is an RBPMS activated exon from Cluster one in panel F.
Tsc2 is an RBPMS repressed exon from Cluster 4 of panel E. Cald1 has an RBPMS activated exon 4 and downstream five splice site on exon 3b. For
Cald1, a manually calculated PSI in parentheses takes into account the A5SS which was not included in the rMATS annotation.
DOI: https://doi.org/10.7554/eLife.46327.011
The following figure supplement is available for figure 3:
Figure supplement 1. RBPMS recapitulates the aorta tissue AS pattern of Vcl, Tpm1 and Cald1.
DOI: https://doi.org/10.7554/eLife.46327.012
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Figure 4. RBPMS directly regulates exons associated with CAC motifs. (A) RBPMS motif (CACN1-12CAC) enrichment in differentially alternatively spliced
cassette exons in the PAC1 dedifferentiation (D Ctr - P Ctr), RBPMS knockdown (D Ctr - D KD) and RBPMS overexpression (P OE - P Ctr) comparisons.
Values indicate degree of motif enrichment (black) or depletion (red). Statistical significance: *p<0.05, **p<0.01,***p<0.001. (B) RBPMS motif (CACN1-
12CAC) map from RBPMS overexpression (P OE - P Ctr). Upregulated (green), downregulated (blue) and unregulated (gray) cassette exons are shown.
Statistical significance: p<0.05, 1000 permutations is indicated by thicker line width. (C) RBPMS overexpression in HEK293 cells and RT-PCR of
endogenous FLNB exon H1 splicing. Schematic of Flnb exon H1 as a differentiated cassette exon activated by RBPMS. The splicing pattern of FLNB
was tested upon overexpression of Venus tagged RBPMS A, B and 2. A mock and a Venus control were also tested in parallel. (D) Effect of RBPMS
overexpression on rat Flnb splicing reporter in HEK293 cells. Schematic of the Flnb reporter and RT-PCR for the splicing patterns of Flnb reporter upon
coexpression of RBPMS isoforms and RBPMS2. (E) Flnb reporter with point mutations disrupting RBPMS motifs (CAC to CCC) were tested for RBPMS A
regulation. Left, wild-type reporter and right, mutant CAC reporter (mCAC) RT-PCRs. (F) Electric mobility shift assay (EMSA) for in vitro binding of
recombinant RBPMS A and B to in vitro transcribed wild-type and mCAC RNAs of Flnb exon H1 downstream intron sequence (top left and right). Lower
panel: UV-crosslinking of same samples. (G) RBPMS overexpression in HEK293 cells and RT-PCR of endogenous TPM1 MXE exon 2 and 3 splicing. The
splicing pattern of TPM1 was tested upon overexpression of Venus tagged RBPMS A, B and 2. A mock and a Venus control were also tested in parallel.
(H) Effect of RBPMS overexpression on rat Tpm1 splicing reporter in HEK293 cells. Schematic of the Tpm1 reporter and RT-PCR for the splicing patterns
of Tpm1 reporter upon RBPMS isoforms and paralog. (I) Tpm1 reporter with point mutations disrupting RBPMS motifs (CAC to CCC) was tested for
RBPMS A regulation. Left, wild-type reporter and right, mutant CAC reporter (mCAC) RT-PCRs. (J) In vitro binding of recombinant RBPMS A and B to in
vitro transcribed wild-type and mCAC RNAs of Tpm1 exon three upstream intron sequence. EMSA, top and UV crosslinking, bottom. In (F) and (J), in
vitro binding assays were carried out using recombinant protein in a serial dilution (1:4) in a range of 0.125 to 2 mM. In panels (C–E) and (G–I), values are
the mean PSI ± sd (n = 3). For Flnb cassette exon, the PSI is the sum of both short and long isoforms generated by a A5SS event. For Tpm1 MXE, the
SM exon PSI is shown (PSI-SM). Schematics of the splicing isoforms indicate the PCR products, differentiated (green) and proliferative (blue). Statistical
significance was calculated using Student’s t-test (*p<0.05, **p<0.01, ***p<0.001). Western blot anti-GFP and GAPDH, loading control, were carried out
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We mutated CAC motifs in suspected binding sites to CCC, which disrupts RBPMS binding
(Farazi et al., 2014). Mutation of 12 CACs downstream of the FlnB H1 exon had no effect on basal
splicing, but the H1 exon was completely resistant to activation by RBPMSA (Figure 4E). Likewise,
mutation of 9 CAC motifs upstream of Tpm1 exon three had no effect on exon inclusion in the
absence of RBPMSA, but completely prevented exon skipping in response to RBPMSA (Figure 4I,
Figure 4—figure supplement 2B), while mutations of individual clusters had intermediate effects
(Figure 4—figure supplement 2B). The response of both Flnb H1 exon and Tpm1 exon three there-
fore depends on nearby CAC motifs. To test whether these are binding sites for RBPMS, we used in
vitro transcribed RNAs and recombinant RBPMSA and B (Figure 4F,J and Figure 4—figure supple-
ment 4). Using both electrophoretic mobility shift assay (EMSA) and UV crosslinking, both RBPMSA
and B were found to bind to the FlnB wild type RNA (apparent Kd ~0.5 mM), but not to the mutant
RNA (Figure 4F). With Tpm1, RBPMSA and B bound to the WT RNA as indicated by EMSA assays
(Kd ~0.5 mM) (Figure 4J). Binding was reduced by the mutations that abrogated RBPMSA repression
of Tpm1 exon 3 (Kd >0.5 mM). Finally, we tested the effects of mutations in RBPMS to disrupt the
RNA binding and dimerization interfaces of the RRM (Sagnol et al., 2014; Teplova et al., 2016).
Both RNA binding and dimerization mutants of RBPMSA had lost all splicing regulatory activity upon
overexpression in HEK293 cells (Figure 4—figure supplement 3), revealing RBPMS dimer-depen-
dent splicing activity. These data therefore show that RBPMS can inhibit splicing by binding to CAC
clusters upstream of exons (Tpm1) and activate splicing by downstream binding (Flnb).
RBPMS-regulated splicing targets the cytoskeleton and cell adhesion
To investigate the functional importance of RBPMS-regulated AS, we carried out Gene Ontology
(GO) analysis of the genes whose splicing or expression levels were regulated by RBPMS
(Figure 5A, Figure 5—figure supplement 1A,Supplementary files 4 and 5), or between SMC dif-
ferentiation states (Figure 5—figure supplement 1B,C). Splicing events affected by RBPMS-knock-
down affected genes involved in processes, components and functions important for SMC biology,
such as cytoskeleton, cell projection, cell junction organization and GTPase regulation (Figure 5A).
These categories were very similar to those affected by AS during PAC1 cell dedifferentiation (Fig-
ure 5—figure supplement 1B). Events regulated by RBPMS knockdown were also enriched within
genes that are associated with super-enhancers in SMC tissues (Figure 5B) and therefore inferred to
be important for SMC identity. In contrast, the relevance of GO terms associated with RBPMSA
overexpression to SMC biology was less clear (Figure 5—figure supplement 1A), despite the pres-
ence of many events that were reciprocally regulated by RBPMS knockdown. RBPMS overexpression
AS targets were also not enriched for aorta super-enhancer-associated genes (p=0.37). This discrep-
ancy might be accounted for by the high level of RBPMS overexpression leading to changes in some
AS events that are not physiological targets. At the RNA abundance level enriched GO terms associ-
ated with RBPMS knockdown or overexpression did not align with those associated with differentia-
tion, mainly being associated with stress responses (Supplementary file 5).
To further explore the consequences of RBPMS regulation of AS we carried out network analysis
using STRING (Szklarczyk et al., 2017) (Figure 5C). To ensure that all target events were biologi-
cally relevant we used only AS events that are coregulated by RBPMS knockdown and PAC1
Figure 4 continued
to assess RBPMS isoform overexpression in HEK293 (panels (C-E, H, I). The western blot in (C) is also a representative of (G), since both RT-PCRs (FLNB
and TPM1) are from the same overexpression experiment.
DOI: https://doi.org/10.7554/eLife.46327.013
The following figure supplements are available for figure 4:
Figure supplement 1. RBPMS promotes the SM splicing of MPRIP and ACTN1 in HEK293 cells.
DOI: https://doi.org/10.7554/eLife.46327.014
Figure supplement 2. RBPMS represses the splicing of the NM exon of Actn1 and Tpm1.
DOI: https://doi.org/10.7554/eLife.46327.015
Figure supplement 3. RBPMS splicing activity requires RNA binding and dimerization.
DOI: https://doi.org/10.7554/eLife.46327.016
Figure supplement 4. RBPMS recombinant proteins.
DOI: https://doi.org/10.7554/eLife.46327.017
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Figure 5. RBPMS regulates functionally important targets in SMCs. (A) GO analysis of genes with cassette exons regulated in RBPMS knockdown. The
top five enriched GO terms in the three categories (biological process, molecular function and cellular component) are shown. Values within and in
front of the bars indicate the number of genes in the enriched term and the enrichment relative to the background list. (B) Enrichment of exons
regulated by RBPMS knockdown within genes associated with super-enhancers in smooth muscle tissues. Background set is all cassette exon events
Figure 5 continued on next page
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differentiation state (Figure 3A,E) or by RBPMS overexpression and in aorta tissue (Figure 3C,F).
We also restricted the output network to high confidence interactions. RBPMS targets comprised a
network (Figure 5C) focused on functions associated with cell-substrate adhesion (yellow nodes) and
the actin cytoskeleton (blue). Six of the network proteins (SORBS1, CALD1, PDLIM5, PDLIM7,
ACTN1 and ARHGEF7) are also components of the consensus integrin adhesome (Horton et al.,
2015), which mechanically connects, and mediates signalling between, the actin cytoskeleton and
the extracellular matrix. Underlining the importance of this network to SMC function, many of the
genes are themselves super-enhancer-associated in one or more smooth muscle tissues (bold text,
Figure 5C). Actomyosin activity, and its mechanical connection to the extracellular matrix are impor-
tant for both the contractile and motile states of SMCs (Min et al., 2012). It appears that RBPMS
plays an important role in modulating the activity of this protein network to suit the needs of the
two cell states. Despite these coordinated changes in AS, we were unable to observe obvious
changes in PAC1 cell phenotype after under the overexpression and knockdown treatments used for
RNA analysis. We reasoned that more sustained perturbation of RBPMS levels might be required to
allow turnover of protein isoforms before phenotypes would become apparent. We therefore pro-
longed RBPMS knockdown to a total of 120 hr (Figure 5D–F and Figure 5—figure supplements 2
and 3). Effective knockdown of RBPMS protein and RNA, and effects upon known RBPMS-regulated
AS events were all confirmed (Figure 5—figure supplement 3). Under these conditions we
observed a modest reduction in levels of smooth muscle actin (Acta2) protein and RNA (Figure 5—
figure supplement 3), which had not been seen with shorter knockdown. Strikingly, we observed
substantial changes in cell morphology and actin organization of differentiated PAC1 cells upon pro-
longed RBPMS depletion. Compared to control cells, PAC1 cells treated with RBPMS siRNA (D KD)
displayed less alignment of actin fibers, as indicated by the lower actin anisotropy score (~0.6 fold),
accompanied by larger nuclear (~1.7 fold) and cell sizes (~2.6 fold) (Figure 5D,F). Remarkably, the
RBPMS knockdown differentiated cells closely resembled the proliferative cells in these characteris-
tics (Figure 5D,E). Therefore, the control of a functionally coherent set of targets that are important
for SMC morphology and function is consistent with the hypothesis that RBPMS is a master regulator
of AS in SMCs.
RBPMS controls post-transcriptional regulators
Among the direct targets of master splicing regulators are expected to be events controlling the
activity of other AS regulators leading to further indirect AS changes. Consistent with this, we noted
Figure 5 continued
(regulated and unregulated) detected by rMATS in the same experiment. Significance determined by hypergeometic P-value. (C) PPI network of genes
showing concordant splicing regulation upon RBPMS knockdown and PAC1 differentiation status, combined with genes concordantly regulated by
RBPMS overexpression and in aorta tissue datasets. PPI network was generated in STRING using experiments and database as the sources of
interactions. Network edges represent the interaction confidence. Enriched GO terms (BP, biological process, MF, molecular function and CC, cellular
component) were also included in the analysis and are indicated in red, blue and yellow. Super-enhancer associated gene names are in bold and are
highlighted gray, light green or dark green shading according to whether they were super-enhancer associated in 1, 2 or 3 SMC tissues. (D)
Immunofluorescence of RBPMS and actin (Phalloidin) in differentiated and proliferative PAC1 cells (D and P) and upon prolonged (120 hr) RBPMS
knockdown in differentiated PAC1 cells (D Ctr and D KD). DAPI staining for cell nuclei. Scale bars 10 mm. (E) Left, anisotropy measurement of actin
fibers in PAC1 cells D (differentiated) and P (proliferative) using the FibrilTool ImageJ macro (n = 44 and 52). Middle, nucleus size measurement shown
in pixels (n = 182 and 130). Right, average of the cell size quantified per field (n = 11 and 15). (F) Left, anisotropy measurement of actin fibers in RBPMS
knockdown (D Ctr and D KD) using the FibrilTool ImageJ macro (n = 56 and 33). Middle, nucleus size measurement shown in pixels (n = 363 and 75).
Right, average of the cell size quantified per field (n = 14 and 10). In (E) and (F), statistical significance was obtained from a Mann-Whitney-Wilcoxon
Test (*p<0.05, **p<0.01, ***p<0.001). Data shown are from one representative experiment carried out in triplicate.
DOI: https://doi.org/10.7554/eLife.46327.018
The following figure supplements are available for figure 5:
Figure supplement 1. GO analysis of genes differentially spliced upon RBPMS overexpression and PAC1 and aorta dedifferentiation.
DOI: https://doi.org/10.7554/eLife.46327.019
Figure supplement 2. Morphological changes in PAC1 cells are specific to RBPMS knockdown.
DOI: https://doi.org/10.7554/eLife.46327.020
Figure supplement 3. Sustained RBPMS knockdown in PAC1 cells.
DOI: https://doi.org/10.7554/eLife.46327.021
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that RBPMS affected splicing of Mbnl1 and Mbnl2. RBPMS promoted skipping of the 36 nt and 95
nt alternative exons of Mbnl1 (here referred to as exons 7 and 8), as indicated by both knockdown
and overexpression (Figure 6A,B). In Mbnl2 the 36 nt exon was fully skipped in all conditions but
the 95 nt exon was repressed by RBPMS (Figure 6C). Consistent with the RNA-Seq data, we
obtained Mbnl1 and Mbnl2 cDNAs from PAC1 cells that varied by inclusion of the 36 and 95 nt
exons. Corresponding shifts in MBNL1, but not MBNL2, protein isoforms could be observed by
western blot (Figure 6D). These events affect the unstructured C-termini of MBNL proteins and have
been shown to affect their splicing activity (Sznajder et al., 2016; Tabaglio et al., 2018; Tran et al.,
2011), suggesting that RBPMS might indirectly affect some AS events by modulating MBNL activity.
To test this, we made expression constructs of rat MBNL1 isoforms with and without exons 7 and 8
(FL, D7, D8, D7D8) and MBNL2 with and without exon 8 (FL and D8), obtained as cDNAs from PAC1
cells. When transfected into HEK293 cells, full length MBNL1 and 2 caused a shift from use of the
downstream to an upstream 5’ splice site (5’SS) on NCOR2 exon 47 (Figure 6E), an event that is dif-
ferentially regulated by MBNL isoforms (Sznajder et al., 2016; Tran et al., 2011). The shorter MBNL
isoforms showed lower activity in shifting towards the upstream 5’SS, although the difference was
not statistically significant for the MBNL1 shorter isoforms (Figure 6E). In proliferative PAC1 cells,
NCOR2 exon 47 mainly uses the upstream 5’SS, and knockdown of MBNL1 and 2 caused a signifi-
cant shift to the downstream 5’SS (Figure 6F). Overexpression of RBPMSA, also caused a small shift
to the downstream 5’SS (Figure 6F, also detected by rMATs, DPSI = 13%, FDR = 210 6), but had
no effect when MBNL1 and MBNL2 were knocked down. These results are consistent with MBNL1
and 2 being direct regulators of Ncor2 splicing, with RBPMS acting indirectly by promoting produc-
tion of less active MBNL isoforms.
Another post-transcriptional regulator affected by RBPMS is LSM14B, which is involved in cyto-
plasmic regulation of mRNA stability and translation (Brandmann et al., 2018) but also shuttles to
the nucleus (Kırlı et al., 2015). RBPMSA overexpression promoted skipping of Lsm14b exon 6, a
pattern which is also seen in tissue SMCs (Figure 6G,H), and knockdown was also seen to affect this
event (Figure 6G,H), with corresponding changes in LSM14B protein (Figure 6I). Exon six contains
the only predicted nuclear localization signal (RPPRRR) in LSM14B (Figure 6H) lying between the
LSM and FDF domains. This suggests that RBPMS mediated AS might prevent nuclear shuttling and
function of LSM14B in mRNA turnover.
RBPMS controls the SMC transcription factor myocardin
Myocardin (MYOCD) is a key transcription factor in SMCs and cardiac muscle (Li et al., 2003). Skip-
ping of Myocd exon 2a in cardiac muscle and proliferative SMCs produces a canonical mRNA encod-
ing full length MYOCD (Figure 7A) (Creemers et al., 2006; van der Veer et al., 2013). Inclusion of
exon 2a in differentiated SMCs introduces an in frame stop codon, and the N-terminally truncated
Myocd isoform produced using a downstream AUG codon lacks the MEF2 interacting domain and is
more potent in activating SMC-specific promoters and SMC differentiation (Creemers et al., 2006;
Imamura et al., 2010; van der Veer et al., 2013). Significant changes in Myocd exon 2a splicing
were not detected by rMATS, but manual inspection of RNA-Seq data and RT-PCR confirmed that
Myocd exon 2a is more included in differentiated than proliferative PAC1 SMCs (Figure 7B) and its
inclusion decreases upon RBPMS knockdown in differentiated PAC1 cells (Figure 7B, Figure 2—fig-
ure supplement 2B). Effects of lentiviral RBPMS-A overexpression were less clear (PSI -
Dox = 37.7 ± 5.1, PSI + Dox = 47.1 ± 11.9), possibly related to the very low Myocd expression in the
transduced lines. A conserved 200 nt region downstream of exon 2a contains two clusters of CAC
motifs (Figure 7C), suggesting that RBPMS directly activates exon 2a splicing. To better understand
the regulation of the Myocd exon 2a, we created a minigene of exon 2a and its flanking intronic
regions. In transfected PAC1 cells exon 2a in the minigene was included to a basal level of ~30%
and RBPMS-A or RBPMS-B significantly increased exon 2a inclusion (Figure 7D). The Myocd mini-
gene was also tested in HEK293 cells. As expected, exon 2a was fully skipped in the non-smooth
muscle cell line, but was highly responsive to RBPMSA and B with inclusion increasing to ~75% and
37%, respectively (Figure 7E). To test the role of the downstream CAC clusters we mutated each
cluster (CAC to CCC mutations). Mutation of cluster 1 (mCAC) had a modest effect on activation by
RBPMSA, although RBPMSB activity was severely impaired. Mutation of cluster two impaired activity
of both RBPMS isoforms, while the combined mutations abolished all activation by RBPMS
(Figure 7E). Insertion of a previously defined RBPMS site (Ube2v1 from Farazi et al., 2014) into the
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Figure 6. RBPMS regulates splicing of post-transcriptional regulators. (A) Sashimi plot of Mbnl1 regulated
exons. The numbers on top of the arches indicate the number of reads mapping to the exon-exon junctions. Mean
of the PSI values calculated for each exon (exon 7–36 bp and exon 8–95 bp) are indicated for each condition (PSI-
ex7 and PSI-ex8). Schematic of the different mRNA isoforms are found at the bottom. (B) RT-PCR validation of
Mbnl1 exons 7 and 8 and (C) Mbnl2. Values shown are the mean of the PSI ± standard deviation (n = 3). The PSI
values for each exon of Mbnl1 are shown. For Mbnl2, exon seven isoforms were not detected in the RT-PCRs.
Schematics of the splicing isoforms identify the PCR products. (D) Western blot probing for MBNL1 and 2 in
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double mutant minigene restored activation by RBPMS-A, although RBPMS-B had minimal activity in
this context (Figure 7G). To confirm binding of RBPMS to the CAC motifs, EMSAs and UV crosslink-
ing were carried out with in vitro transcribed RNAs containing the wild-type and mutant CAC clus-
ters (Figure 7F). RBPMS A and B were both able to bind to the wild-type RNA at similar affinities as
indicated by EMSA (apparent Kd ~0.5 mM) (Figure 7F upper panels). Binding was modestly reduced
by mutation of the first cluster (Kd ~0.5–2.0 mM), more severely affected by mutation of the second
cluster (Kd ~2.0 mM), and eliminated by combined mutation of both clusters. UV crosslinking of
RBPMS was inefficient with only a very faint signal evident with wild type, but not mutant, probes
(Figure 7F lower panels). These data therefore indicate that RBPMS directly activates Myocd exon
2a inclusion via downstream CAC clusters.
Myocd exon 2a is repressed by binding of the RBP QKI to the 5’ end of the exon (van der Veer
et al., 2013). QKI is expressed more highly in proliferative SMCs (Llorian et al., 2016; van der Veer
et al., 2013) suggesting that RBPMS and QKI could act antagonistically on AS events during pheno-
typic switching. To test for functional antagonism, we co-transfected the Myocd minigene with the
two RBPs in HEK293 cells (Figure 7H). QKI strongly antagonized RBPMS activitation of exon 2a
inclusion, even at low concentrations, showing it to be the dominant regulator (Figure 7H). Thus,
splicing of Myocd exon 2a, and thereby the transcriptional activity of Myocd, is under the antagonis-
tic control of RBPs that are preferentially expressed in differentiated (RBPMS) or proliferative (QKI)
SMCs.
Discussion
Using super-enhancers to identify master splicing regulators
By focusing on RBPs whose expression is driven by super-enhancers (Jangi and Sharp, 2014) we
identified RBPMS as a key regulator of the differentiated SMC AS program, with many of the criteria
expected of a master regulator: i) it is highly up-regulated in differentiated SMCs (Figure 1, Fig-
ure 1—figure supplements 1–3). Indeed, single cell RNA-Seq identified Rbpms as part of a tran-
scriptome signature of contractile mouse aorta SMCs cells (Dobnikar et al., 2018); ii) changes in
RBPMS activity appear to be solely responsible for 20% of the AS changes between differentiated
and proliferative PAC1 cells (Figure 3); iii) RBPMS target splicing events are enriched in functionally
coherent groups of genes affecting cell-substrate adhesion and the actin cytoskeleton, which are
important for SMC cell phenotype-specific function (Figure 5); iv) it regulates splicing and activity of
other post-transcriptional regulators in SMCs (Figure 6), and v) it regulates splicing of the key SMC
transcription factor MYOCD (Figure 7) to an isoform that promotes the contractile phenotype
(van der Veer et al., 2013).
RBPMS is reported to be a transcriptional co-activator (Fu et al., 2015; Sun et al., 2006). How-
ever, we did not observe changes in expression levels of SMC marker genes upon RBPMS knock-
down or overexpression and changes in RNA abundance were outnumbered by regulated AS events
Figure 6 continued
RBPMS knockdown and overexpression shows the MBNL1 isoform switch at the protein level. (E) Schematic of the
different MBNL1 protein isoforms, left. Different MBNL1 and MBNL2 isoforms were overexpressed in HEK293T
cells and their effect on an A5SS event in the NCOR2 gene assessed. Schematics of NCOR2 splicing isoforms
indicates the PCR products. Western blot were probed against FLAG to verify isoform overexpression. PSI
indicates use of the downstream A5SS to generate the longer isoform. (F) MBNL1 and 2 knockdown in inducible
RBPMS A or in lentiviral control (P LV) proliferative PAC1 cells to assess the dependency of the Ncor2 A5SS event
to the MBNL1 isoform switch. Western blot for MBNL1 and 2 and FLAG to confirm MBNL knockdown and RBPMS
A overexpression. In all the western blots TUBULIN was used as a loading control. Statistical significance was
calculated using Student’s t-test (*p<0.05, **p<0.01, ***p<0.001). (G) Sashimi plot of the Lsm14b cassette exon
regulated by RBPMS. PSI values represent the mean of the PSI values calculated by rMATS analysis. (H) RT-PCR
validation of Lsm14b in the RBPMS knockdown and overexpression in PAC1 cells. Schematic of the Lsm14b event
at the top and schematic of its isoforms at the left. Peptide sequence coded by the exon is shown below the
schematic. (I) Western blot of LSM14B in RBPMS knockdown and overexpression cells. GAPDH was used for
loading control.
DOI: https://doi.org/10.7554/eLife.46327.022
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Figure 7. RBPMS controls splicing of the SMC transcription factor Myocd exon 2a. (A) Schematic of Myocd exon
2a ASE and its functional consequences upon MYOCD protein domains. (B) RT-PCR of Myocd exon 2a splicing in
the PAC1 Differentiated (D) and Proliferative (P) PAC1 cells, left) and in differentiated PAC1 cells treated with
control (D Ctr) or RBPMS siRNAs (D KD), right. (C) Schematic of the Myocd exon 2a splicing reporter. The two
main clusters of CAC motifs, found downstream of exon 2a, are highlighted in red. (D) RT-PCRs of the effects of
RBPMS A and B overexpression on Myocd exon 2a in PAC1 cells. Reporter only and Venus controls were tested
alongside. Protein expression levels are shown in the western blot probing for GFP and GAPDH as a loading
control. (E) RT-PCR of the effects of RBPMS A and B overexpression on Myocd exon 2a splicing reporter in
HEK293. RBPMS CAC sites were mutated and response to RBPMS validated by RT-PCR. Schematic of the different
mutant Myocd exon 2a splicing reporters are found at the top. RBPMS overexpression was confirmed by western
blot using GAPDH as a loading control. (F) In vitro binding of RBPMS A and B to Myocd exon 2a downstream
intron sequence in EMSA, top, and in UV-crosslink, bottom. In vitro transcribed wild-type and different mCAC
RNAs were incubated with recombinant RBPMS (0.125 to 2 mM). (G) The UBE2V1 sequence identified to bind to
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(Figure 2). As a splicing regulator RBPMS can only affect actively transcribed genes, so it is unlikely
to be sufficient to initially drive SMC differentiation. Notably, we identified RBPMS using super-
enhancers mapped in adult human tissues (Hnisz et al., 2013). Combined with the ability of RBPMS
to promote AS patterns characteristic of fully differentiated tissue SMCs, such as in Cald1, Fermt2
and Tns1 (Figure 3F,G), this suggests that RBPMS plays a key role in maintaining a mature adult
SMC phenotype. Consistent with a role in promoting a fully differentiated state, in other cell types
RBPMS has anti-proliferative tumor-suppressive activity (Fu et al., 2015; Hou et al., 2018;
Rastgoo et al., 2018).
RBPMS is an alternative splicing regulator
RBPMS and RBPMS2 (referred to as Hermes in Xenopus) are present across vertebrates, while the
related proteins Drosophila Couch Potato and C. elegans MEC-8 bind to similar RNA sequences
(Soufari and Mackereth, 2017). RBPMS and RBPMS2 can localize to the cytoplasm and nucleus, but
apart from transcriptional co-regulation (Fu et al., 2015; Sun et al., 2006) most attention has been
paid to cytoplasmic roles in mRNA stability (Rambout et al., 2016), transport (Ho¨rnberg et al.,
2013) and localization in cytoplasmic granules (Farazi et al., 2014; Furukawa et al., 2015;
Ho¨rnberg et al., 2013). RBPMS2 interacts with eukaryote elongation factor-2 (eEF2) in gastrointesti-
nal SMCs, suggesting translational control (Sagnol et al., 2014). MEC-8 was reported to regulate
splicing of Unc-52 in C. elegans (Lundquist et al., 1996), but otherwise RBPMS family members
have not been reported to regulate splicing. PAR-CLIP with over-expressed RBPMS in HEK293 cells
revealed its preferred binding site, but accompanying mRNA-Seq did not identify regulated AS
events associated with PAR-CLIP peaks (Farazi et al., 2014). Using rMATS to re-analyze the RNA-
Seq data of Farazi et al, we found a small number of regulated AS events, including the Flnb H1
exon (Figure 4C–F). We readily detected specific binding of RBPMS to target RNAs by EMSA, but
UV crosslinking was inefficient, even with purified protein and in vitro transcribed RNA (Figures 4F,J
and 7F). This suggests that CLIP might significantly under-sample authentic RBPMS-binding sites.
Nevertheless, the functional binding of RBPMS to Flnb, Tpm1 and Myocd RNAs (Figures 4 and
7), the strong enrichment of dual CAC motifs with RBPMS-regulated exons (Figure 4A), the associ-
ated requirement for RBPMS RNA binding and dimerization (Figure 4—figure supplement 3), and
distinct positional signatures for activation and repression of splicing (Figure 4A,B), indicate that
RBPMS acts widely to directly regulate splicing in differentiated SMCs. While earlier reports have
shown that RBPMS can act in other steps in gene expression, our data provide the strongest evi-
dence to date for a widespread molecular function of RBPMS as a splicing regulator.
Cell-specific splicing programs are usually driven by more than one regulatory RBPs. A number of
splicing regulatory RBPs are known to promote the proliferative SMC phenotype, including QKI,
PTBP1, and SRSF1 (Llorian et al., 2016; van der Veer et al., 2013; Xie et al., 2017). The extent to
which these proteins coordinately regulate the same target ASEs remains to be established. RBPMS
and QKI antagonistically regulate at least two targets in addition to Myocd (Figure 7). The Flnb H1
exon is activated by RBPMS (Figure 2—figure supplement 3A, Figure 4) and repressed by QKI
(Li et al., 2018), while the penultimate exon of Smtn is repressed by RBPMS (Figure 2—figure sup-
plement 3A) but activated by QKI (Llorian et al., 2016). Moreover, QKI binding motifs are signifi-
cantly associated with exons regulated during SMC dedifferentiation, and with exons directly
regulated by RBPMS overexpression or knockdown (data not shown). It is therefore an interesting
possibility that RBPMS and QKI might target a common set of ASEs perhaps acting as antagonistic
master regulators of differentiated and proliferative SMC phenotypes. The two RBPs show reciprocal
Figure 7 continued
RBPMS by PAR-CLIP (Farazi et al., 2014) was inserted into the mCAC Myocd reporter. Schematic of the mCAC
Myocd exon 2a splicing reporter and the UBE2V1 sequence. RT-PCR of the effects of RBPMS A and B
overexpression on Myocd reporter in HEK293 cells. Western blot probing for GFP and GAPDH as a loading
control. (H) Effects of the co-expression of RBPMS and QKI, a Myocd exon 2a repressor, on Myocd exon 2a
reporter in HEK293. Myocd 2a reporter schematic with QKI and potential RBPMS-binding sites indicated. RBPMS
and QKI overexpression was confirmed by western blot against GFP and GAPDH as a loading control. In GFP
western blots, ‘*’ indicates the GFP product from the splicing reporter.
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regulation of expression levels during SMC dedifferentiation (Figure 1—figure supplement 2B,C),
which combined with antagonistic activities could lead to switch like changes in many ASEs. For
Myocd splicing, QKI appears to have dominant activity, driving skipping of exon 2a even when
RBPMS is present at higher levels (Figure 7G), so full inclusion of exon 2a requires the presence of
RBPMS and absence of QKI. The logic of this regulatory input can explain inclusion of Myocd exon
2a in SMC and skipping in cardiac muscle and is consistent with the observation that RBPMS is
super-enhancer associated both in vascular SMCs and heart left ventricle, while QKI is super-
enhancer associated in left ventricle but not differentiated SMCs. Notably, QKI also controls a signifi-
cant fraction of ASEs regulated during myogenic differentiation of skeletal muscle cells, but it pro-
motes differentiated myotube AS patterns (Hall et al., 2013), in contrast to its promotion of
dedifferentiated splicing patterns in SMCs.
Activity of RBPMS isoforms
RBPMS was originally characterized as a human gene that encoded multiple isoforms of an RBP
(Shimamoto et al., 1996), but differential activity of common RBPMS isoforms has not previously
been reported. Human RBPMSA and B have similar activity for co-regulation of AP1 transcriptional
activity (Fu et al., 2015) although a third human-specific isoform had lower activity. We found differ-
ential activity of RBPMSA and B upon some ASEs (Figures 4 and 7). In general, RBPMSA has higher
activity particularly for repressed targets (Figure 4F, Figure 4—figure supplements 1A and
2A). The differential activity was seen with similar levels of overall expression, although we could not
rule out the possibility of variation in nuclear levels as GFP-tagged RBPMS was predominantly cyto-
plasmic. Nevertheless, some ASEs were differentially responsive to RBPMSA or B while others
responded equally (e.g. compare MPRIP with ACTN1, Figure 4—figure supplement 1A). The differ-
ential activity upon Tpm1 splicing could not be accounted for by differences in RNA binding by
RBPMSA or B (Figure 4F,H). Therefore, it is possible that RBPMS repressive function depends on
other interactions mediated by the 20 amino acid RBPMSA C-terminal (Figure 1C). While the RRM
domain is sufficient for RNA binding and dimerization in vitro (Sagnol et al., 2014; Teplova et al.,
2016), previous studies have shown the extended C terminal region downstream of the RRM domain
to be involved in several aspects of RBPMS/RBPMS2 function including granular localization in retinal
ganglion cells (Ho¨rnberg et al., 2013) and interaction with cFos in HEK293 cells (Fu et al., 2015). In
vitro assays suggested that the C-terminal region increases RNA-binding affinity and possibly the
oligomeric state of RBPMSA (Farazi et al., 2014) and the C-terminal 34 amino acids of Xenopus
RBPMS2 is required for binding to Nanos1 RNA in vivo (Aguero et al., 2016). In preliminary studies
we have also found the C-terminal region to be essential for splicing regulation (data not shown).
Future work will aim to address the mechanisms of RBPMS splicing activation and repression as well
as isoform-specific differential activity.
RBPMS targets numerous mRNAs important for SMC function
SMC phenotypic switching involves interconversion between a contractile phenotype and a motile,
secretory, proliferative state (Owens et al., 2004). The actin cytoskeleton and its connections to the
extracellular matrix (ECM) via focal adhesions are central to the function of both cell states, but with
contrasting outcomes: tissue-wide contraction or independent movement of individual cells. RBPMS-
mediated AS plays a major role in remodelling the actin cytoskeleton, the integrin adhesome
(Horton et al., 2015) and ECM components in the two cell states. This is reflected in the similar GO
terms shared by RBPMS-regulated AS events and the entire PAC1 cell AS program and in the mor-
phological changes, including actin fiber reorganization, observed upon RBPMS knockdown in PAC1
cells (Figure 5, Figure 5—figure supplements 1 and 2). The importance of many of the RBPMS tar-
get genes to SMC function is further indicated by their proximity to super-enhancers in SMC tissues
(Figure 5B,C). Indeed, three targets - ACTN1, FLNB and TNS1 - are all super-enhancer associated,
interact directly with both actin and integrins and are components of distinct axes of the consensus
integin adhesome (Horton et al., 2015). ACTN1 is a major hub in the network of proteins affected
by RBPMS (Figure 5C). The AS event in ACTN1 produces a functional Ca2+-binding domain in the
motile isoform, but lack of Ca2+ binding in the differentiated isoform stabilizes ACTN1 containing
structures in contractile cells (Waites et al., 1992). Many other RBPMS-regulated AS events have
not previously been characterized. Focal adhesion complexes and the integrin adhesome are
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mechanosensitive complexes that connect the cytoskeleton and ECM, and are hubs of regulatory
tyrosine phosphorylation signalling. We found a small network of RBPMS-regulated AS events in the
receptor tyrosine phosphatase PTPRF (Figure 2E) and two interacting proteins PPFIA1 and PPFIBP1
(Figure 2—figure supplement 3A). Another focal adhesion associated target is PIEZO1 (Figure 2E),
a mechanosensitive ion channel that is important in SMCs during arterial remodelling in hypertension
(Retailleau et al., 2015). An RBPMS repressed exon lies within the conserved Piezo domain immedi-
ately adjacent to the mechanosensing ‘beam’ (Liang and Howard, 2018). ECM components
affected by RBPMS include fibronectin (FN1), which interacts directly with integrins, and HSPG2 (Fig-
ure 2—figure supplement 3A). Notably, HSPG2 (also known as Perlecan) is the basement mem-
brane heparan sulfate proteoglycan that is the identified splicing target of MEC-8 in C. elegans
(Lundquist et al., 1996).
In addition to direct regulation of numerous functionally related targets, by directly targeting
transcriptional and post-transcriptional regulators RBPMS has the potential for more widespread
action (Figures 6 and 7). RBPMS-regulated events in MBNL1 and 2 modulate their splicing regula-
tory activity (Sznajder et al., 2016; Tabaglio et al., 2018; Tran et al., 2011). Changes in secondary
AS targets are challenging to observe in a short duration overexpression experiment. Nevertheless,
the modest change in NCOR2 splicing appears to be attributable to an RBPMS-induced switch to
less active MBNL isoforms (Figure 6F). The regulated event in LSM14B (Figure 6G–I) also has the
potential to regulate mRNA stability, or an as yet uncharacterized nuclear role of LSM14B
(Kırlı et al., 2015).
We also identified the SMC transcription factor as a direct target of RBPMS (Figure 7). A similar
role has been shown for the proposed myogenic AS master regulator RBM24 (Jangi and Sharp,
2014), which stabilizes mRNA of the transcription factor Myogenin by binding to its 3’UTR
(Jin et al., 2010). Similarly, by activating inclusion of Myocd exon 2a (Figure 7), RBPMS directs pro-
duction of a Myocardin isoform that more potently promotes the differentiated SMC phenotype
(van der Veer et al., 2013). Additional effects upon transcription could also be conferred by RBPMS
activation of the FLNB H1 exon (Figure 2—figure supplement 3A, Figure 4). FLNB is primarily an
actin binding and adhesion protein, but inclusion of the H1 hinge domain allows nuclear localization
and antagonism of the transcription factor FOXC1 in epithelial cells (Li et al., 2018). FOXC1 and
FOXC2 are expressed at higher levels in adult arteries than any other human tissue
(GTEx Consortium, 2013). The modulation by RBPMS of FLNB isoforms therefore provides another
route for indirect transcriptome regulation. The importance of Filamin RNA processing in SMCs by
adenosine to inosine editing of FLNA was also recently highlighted by the cardiovascular phenotypes
arising from disruption of this editing (Jain et al., 2018). A number of splicing regulators also influ-
ence miRNA processing (Michlewski and Ca´ceres, 2019), so it is an interesting possibility that
RBPMS might affect processing of SMC miRNAs such as miR143-145 (Boettger et al., 2009;
Cordes et al., 2009).
RBPMS2 plays an important role in SMCs of the digestive tract. The RBPMS2 gene is associated
with super-enhancers in stomach smooth muscle (Supplementary file 1) and is expressed early in
visceral SMC development and at lower levels in mature cells (Notarnicola et al., 2012). Ectopic
RBPMS2 overexpression led to loss of differentiated contractile function via translational upregula-
tion of Noggin (Notarnicola et al., 2012; Sagnol et al., 2014). This contrasts with our observations
that RBPMS exclusively promotes differentiated SMC AS patterns. RBPMS2 is expressed at low lev-
els in PAC1 and primary aorta SMCs (Figure 1) and its knockdown was without effect. Nevertheless,
ectopic expression of RBPMS2 in PAC1 or HEK293 cells promoted differentiated SMC AS patterns
in a similar manner to RBPMSA (Figure 4, Figure 4—figure supplements 1 and 2), suggesting that
RBPMSA and RBPMS2 have intrinsically similar molecular activities. The reasons for the apparent dis-
crepancy between the promotion by RBPMS2 of differentiated SMC splicing patterns, but de-differ-
entiated visceral SMC phenotypes, remain to be resolved. Possible explanations include variations in
cell-specific signalling pathways, pre-mRNA and mRNA targets, interacting protein partners, post-
translational modifications and subcellular localization, all of which could differentially modulate
RBPMS and RBPMS2 activity in different SMC types.
In conclusion, our data vindicate the proposal that tissue-specific AS master regulators might be
identified by the association of their genes with superenhancers (Jangi and Sharp, 2014), paving
the way for the identification of further such regulators in other tissues. While our data suggest that
RBPMS has a critical role in SMCs, it is likely to play important roles in other cell types where its
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expression is also super-enhancer driven, including cardiac muscle and embryonic stem cells. Our
approach aimed to identify AS master regulators common to diverse smooth muscle types (vascular,
bladder, stomach). However, SMCs show a great deal of diversity (Fisher, 2010), even within single
blood vessels (Cheung et al., 2012). The splicing regulator Tra2 b is responsible for some splicing
differences between tonic and phasic SMCs (Shukla and Fisher, 2008), and it is possible that other
RBPs might act as master regulators of some of these specialized SMC types. Our future studies aim
to understand the mechanisms of splicing regulation by RBPMS, the role of the RBPMS-regulated
splicing program in controlling different aspects of SMC phenotype and the potential role of subver-
sion of this program in cardiovascular diseases. While the changes in actin organization observed
upon RBPMS knockdown were striking (Figure 5), it will be important to directly test various func-
tional readouts of SMC physiology related to actin function and cell adhesion, including cell motility
and agonist-induced cell contraction. VSMCs can be generated by controlled differentiation from
human embryonic stem cells (Cheung et al., 2012). In combination with the use of genomic safe har-
bors to allow inducible protein or shRNA expression, these cells provide an ideal model system in
which to test the effects of RBPMS on VSMC differentiation and function. In the longer term, condi-
tional knockout mouse models will provide invaluable insights into the role of RBPMS in vivo.
Materials and methods
Key resources table
Reagent type (species) or resource Designation Source or reference Identifiers Additional information
Gene
(R. norvegicus)
RBPMSA NCBI:
XM_006253240.2;
XP_006253302.1
See Material
and methods
Gene
(R. norvegicus)
RBPMSB NCBI:
NM_001271244.1;
NP_001258173.1
See Material
and methods
Gene
(R. norvegicus)
RBPMS2 NCBI:
NM_001173426.1;
NP_001166897.1
See Material
and methods
Cell line
(R. norvegicus)
Rat PAC1 pulmonary
artery SMCs
Rothman
et al., 1992
PMID: 1333373
PAC1 Cells from the
original
derivation
of the line
Cell line
(H. sapiens)
HEK293 Lab stock HEK293
Cell line
(H. sapiens)
HEK293T Lab stock HEK293T
Transfected
construct
(R. norvegicus)
effectors and
minigenes
this study See Material
and methods
and
Supplementary file 6
Biological
sample
(R. norvegicus)
Aorta tissue this study T See Material
and methods
Biological
sample
(R. norvegicus)
Dispersed VSMC this study SC See Material
and methods
Biological
sample
(R. norvegicus)
Passage 0 this study P0 See Material
and methods
Biological
sample
(R. norvegicus)
Passage 9 this study P9 See Material
and methods
Antibody Mouse
monoclonal
anti-ACTA2
Agilent/Dako Agilent/Dako:
M0851
See
Supplementary file 6
Continued on next page
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Continued
Reagent type (species) or resource Designation Source or reference Identifiers Additional information
Antibody Rabbit
monoclonal
anti-CALD1
Abcam Abcam: 32330 See
Supplementary file 6
Antibody Rabbit
polyclonal
ani-GAPDH
Santa Cruz Santa Cruz:
sc-25778
See
Supplementary file 6
Antibody Rabbit
polyclonal
anti-LSM14b
Sigma Aldrich Sigma Aldrich:
HPA041274
See
Supplementary file 6
Antibody Rabbit
polyclonal
anti-MBNL1
in-house antibody NA See
Supplementary file 6
Antibody Rabbit
polyclonal
anti-MBNL2
Santa Cruz Santa Cruz:
sc-134813
See
Supplementary file 6
Antibody Rabbit
polyclonal
anti-RBPMS
Sigma Aldrich Sigma Aldrich:
HPA056999
See
Supplementary file 6
Antibody Rat
monoclonal
anti-TUBULIN
Abcam Abcam: ab6160 See
Supplementary file 6
Antibody Mouse
monoclonal
anti-FLAG
Sigma Aldrich Sigma Aldrich:
F-1804
See
Supplementary file 6
Antibody Rabbit
polyclonal
anti-GFP
Invitrogen Invitrogen:
A-11122
See
Supplementary file 6
Recombinant
DNA reagent
pEGFP-C1 Clontech GenBank
Accession: U55763
in vivo
transfection
Recombinant
DNA reagent
pCI-neo-3x-FLAG Rideau et al., 2006
PMID: 16936729
in vivo
transfection
Recombinant
DNA reagent
pET21d Novagen Novagen: 69743-3 protein
expression
in E. coli
Recombinant
DNA reagent
pCAGGs-EGFP this lab Wollerton et al., 2004 minigene
reporter;
see Material
and methods
Recombinant
DNA reagent
pT2 this lab Gooding et al., 2013 minigene
reporter;
see Material
and methods
Recombinant
DNA reagent
ACTN1 reporter this lab Gromak et al., 2003 minigene
reporter;
see
Material
and methods
Recombinant
DNA reagent
pDONR221 Invitrogen Invitrogen:
12536017
GATEWAY
cloning
Recombinant
DNA reagent
pINDUCER 22 Meerbrey
et al., 2011
PMID: 21307310
pINDUCER 22 lentivirus production;
see Material
and methods
Recombinant
DNA reagent
pINDUCER
22-RBPMSA
This study pInducer22
-RBPMSA
See Materials
and methods
Continued on next page
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Continued
Reagent type (species) or resource Designation Source or reference Identifiers Additional information
Recombinant
DNA reagent
pGEM4Z Promega Promega: P2161 in vitro
transcription
templates;
see Material
and methods
Sequence-
based reagent
oligonucleotides Sigma Aldrich See Supplementary file 6
Sequence-
based reagent
Control siRNA Dharmacon C2 custom siRNA See Material
and methods
Sequence-
based reagent
RBPMS siRNA Stealth siRNAs
Thermo Fisher
Scientific
RSS363828; KD1 See Material
and methods
Sequence-
based reagent
RBPMS siRNA Stealth siRNAs
Thermo Fisher
Scientific
RSS363829; KD2 See Material
and methods
Sequence-
based reagent
RBPMS siRNA Stealth siRNAs
Thermo Fisher
Scientific
RSS363830; KD3 See Material
and methods
Sequence-
based reagent
MBNL1 siRNA Dharmacon THH2 siRNA;
Gooding et al., 2013
See Material
and methods
Sequence-
based reagent
MBNL2 siRNA Dharmacon Gooding et al., 2013 See Material
and methods
Peptide,
recombinant
protein
T7-FLAG-RBPMSA-H6 this paper See Material
and methods
and Supplementary file 6
Peptide,
recombinant
protein
T7-FLAG-RBPMSB-H6 this paper See Material
and methods
and Supplementary file 6
Chemical
compound, drug
Phalloidin Invitrogen Alexa Fluor 488
phalloidin; A12379
See Material
and methods
Software,
algorithm
ImageJ https://imagej.nih.
gov/ij/download.html
1.8.0_172 See Material
and methods
Software,
algorithm
FibrilTool
plugin
Boudaoud et al., 2014
PMID: 24481272
See Material
and methods
Software,
algorithm
AxioVision Zeiss v4.8.2 See Material
and methods
Software,
algorithm
Rstudio http://www.rstudio.com/ R version 3.3.3 See Material
and methods
Other DAPI staining Thermo Fisher
Scientific
ProLong
Diamond
Antifade
Mountant
with DAPI; P36966
See Material
and methods
Identification of potential master AS regulators
Locations of human super-enhancers (genome build Hg19) were taken from the data sets UCS-
D_Aorta, UCSD_Bladder, BI_Stomach_Smooth_Muscle and BI_Skeletal_Muscle in Hnisz et al.
(2013). Associated genes were obtained using the UCSD Table Browser (GREAT version 3.0.0) with
the Association rule: ‘Basal +extension: 5000 bp upstream, 1000 bp downstream, 1000000 bp max
extension, curated regulatory domains included’. The list of super-enhancer associated genes from
the dbSUPER database consists of genes assigned more stringently to super-enhancers within a 50
kb window or where experimental verification was available (Khan and Zhang, 2016). We used the
1542 human RBPs from Gerstberger et al. (2014) to identify potential master AS regulators within
each set of super-enhancer proximal genes (Supplementary file 1).
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DNA constructs
Coding sequences of rat Rbpms isoforms were PCR amplified from differentiated PAC1 cell cDNA
and cloned into XhoI/EcoRI sites of the pEGFP-C1 vector (Clontech) and into EcoRI/XhoI sites of the
pCI-neo-3x-FLAG vector (Rideau et al., 2006) to generate N-terminal Venus and 3xFLAG tagged in
vivo overexpression constructs. The two major Rbpms isoforms identified were RBPMS A
(XM_006253240.2/XP_006253302.1) and RBPMS B (NM_001271244.1/NP_001258173.1). RNA bind-
ing (K100E) and dimerization (R38Q and R38A/E39A) mutants, previously described in Farazi et al.
(2014), were generated by site-directed mutagenesis of RBPMS A. QKI construct has been
described in a previous study (Llorian et al., 2016).
Splicing reporters of Tpm1 exon three and Actn1 exon NM and SM were described in
Gooding et al. (2013); Gromak et al. (2003). Myocd exon 2a and Flnb exon H1 splicing reporters
were obtained by PCR amplification of the target exons and respective flanking intron regions from
genomic PAC1 DNA, approximately 250 bp upstream and downstream for Myocd and 500 bp for
Flnb. PCR products were subsequently cloned into XhoI/EcoRV and NotI/SphI sites of pCAGGs-
EGFP vector, which contains a GFP expression cassette with an intron inserted into its second codon
(Wollerton et al., 2004). Point mutations of the CAC motifs in the splicing reporters were generated
by PCR using oligonucleotides that contained A to C mutations. Intronic regions containing CACs
from Tpm1, Flnb and Myocd were PCR amplified and cloned into HindIII/EcoRI sites of pGEM4Z
(Promega) for in vitro transcription. DNA constructs were confirmed by sequencing. All the oligonu-
cleotides used for cloning and mutagenesis are found in Supplementary file 6.
Cell culture, transfection and inducible lentiviral cells
All cell lines were tested for mycoplasma contamination by RNA capture ELISA, and tested negative.
Rat PAC1 pulmonary artery SMCs (Rothman et al., 1992) were grown to a more differentiated or
proliferative state as described in Llorian et al. (2016). HEK293 and HEK293T cells were cultured fol-
lowing standard procedures. Rbpms siRNA mediated knockdown in PAC1 cells was performed as in
Llorian et al. (2016). Briefly, 105 differentiated PAC1 cells were seeded in a six well plate. After 24
hr, cells were transfected using oligofectamine reagent (Invitrogen) and 90 pmols of Stealth siRNAs
from Thermo Fisher Scientific (siRNA1: RSS363828, GGCGGCAAAGCCGAGAAGGAGAACA). A sec-
ond treatment was performed after 24 hr using lipofectamine2000 (Thermo Fisher) and siRNA at the
same concentration of the first treatment. Total RNA and protein were harvested 48 hr after the sec-
ond knockdown. C2 scrambled siRNA was used as a control in the knockdown experiments (Dharma-
con, C2 custom siRNA, AAGGUCCGGCUCCCCCAAAUG). To assess morphological changes in
PAC1 cells upon RBPMS knockdown, the last siRNA treatment with lipofectamine2000 was repeated
48 hr after the second knockdown. PAC1 cells were then assessed 48 hr after the last treatment (120
hr after first siRNA treatment).
For Mbnl1 and Mbnl2 siRNA knockdown, the Mbnl1 THH2 siRNA (CACGGAAUGUAAAUUUGCA
UU) and Mbnl2 specific siRNA (Dharmacon, GAAGAGUAAUUGCCUGCUUUU) were used
(Gooding et al., 2013).
3xFLAG N-terminally tagged rat RBPMSA cDNA was cloned into pInducer22 (Meerbrey et al.,
2011) using the Gateway system. Generation of stable PAC1 cell lines with pInducer22 vector only
(LV) or pInducer22-RBPMSA was done as follows. Lentiviral particles were produced in HEK293T cells
by transient transfection using 30 ml of Mirus TransIT-lenti (MIR6604), 7 mg 3xFLAG tagged RBPMSA
cDNA and 0.75 mg of the packaging plasmids gag, pol, tat and VSV-G transfecting 2  106 cells per
10 cm dish. After 24 hr the medium was transferred to 4˚C and replaced with fresh medium. After a
further 24 hr the medium was removed, pooled with the first batch, spun at 1000 g for 5 min and fil-
tered through 0.45 micron PVDF filter. Lentiviral particles were diluted 1:2 with fresh DMEM medium
containing Glutamax, 10% FBS and 16 mg/ml polybrene and used to replace the medium on PAC1
cells plated 24 hr earlier at 104/35 mm well, setting up two wells for pInducer22 vector only and six
wells for RBPMSA. Fresh medium was added 24 hr later and the populations amplified as necessary.
To induce expression of 3xFLAG RBPMSA the cells were plated at 4  105 cells per 35 mm well ±1
mg/ml doxycycline harvesting RNA and protein 24 hr later.
For transient transfections of HEK293 cells with splicing reporters and effectors, lipofectamine
2000 reagent was used and cells harvested 48 hr after transfection. To verify knockdown and trans-
fection efficiency, total cell lysates were obtained by directly adding protein loading buffer to the
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cells. Lysates were run on a SDS-PAGE, followed by western blot against RBPMS and loading con-
trols. See Supplementary file 6 for information on the antibodies used in this study. To monitor
changes in splicing and mRNA abundance, RNA was extracted using TRI reagent (Sigma) according
to manufacturer’s instructions, DNase treated with Turbo DNA-free kit (Thermo Fisher) and cDNA
synthesized, as described below, followed by PCR and QIAxcel or qRT-PCR analysis.
qRT-PCR and RT-PCR
cDNA was prepared using 1 mg total RNA, oligo(dT) or gene-specific oligonucleotides and Super-
Script II (Life technologies) or AMV RT (Promega) as described in manufacturer’s protocol. qRT-PCR
reactions were prepared with 50 ng of cDNA, oligonucleotides for detection of mRNA abundance
and SYBER Green JumpStart Taq Ready Mix (Sigma). Three-step protocol runs were carried out in a
Rotor-Gene Q instrument (QIAGEN). Analysis was performed in the Rotor-Gene Q Series Software
1.7 using the Comparative Quantitative analysis. To normalize the relative expression values, two
housekeeper genes were included in each experiment (Gapdh and Rpl32) and their geometric mean
used for normalization. Expression values were acquired from biological triplicates.
PCRs with 50 ng of the prepared cDNAs were carried out to detect the different mRNA splicing
isoforms of the reporters using the oligonucleotides detailed in Supplementary file 6. For visualiza-
tion and quantification of the PSI values, PCR products were resolved in a Qiaxcel Advanced System
(QIAGEN) and PSI calculated within the QIAxcel ScreenGel software. A minus RT cDNA, representa-
tive of each triplicate, and a no template PCR reactions were also included in all the experiments
(data not shown). Statistical significance was tested as previously described for gene expression
(paired Student t-test for lentiviral experiments). PSI values are shown as mean (%) ± standard devia-
tion (sd). For lentiviral RBPMSA overexpression, DPSI values determined by RT-PCR were derived
from at least three independent transductions, and no events responded to doxycycline treatment in
cells transduced with the empty pINDUCER22 vector (Figure 2—figure supplement 2A). Statistical
significance was tested by a two-tailed Student’s t test, paired for lentiviral experiments and
unpaired for all the others (*p<0.05, **p<0.01, ***p<0.001).
Immunostaining
For immunodetection of RBPMS in PAC1 cells, differentiated and proliferative cells were grown on
coverslips, fixed with 4% paraformaldehyde (PFA) for 5 min, rinsed with phosphate buffer saline
(PBS) and permeabilized with 0.5% NP-40 for 2 min followed by PBS washes. Coverslips were incu-
bated with blocking buffer (1% BSA in PBS) for 1 hr and incubated with RBPMS primary antibody
diluted in blocking buffer for another hour. Coverslips were rinsed and secondary antibody in block-
ing buffer applied to the coverslips which were incubated for 1 hr. Coverslips were washed and
mounted on ProLong Diamond Antifade with DAPI (Thermo Fisher Scientific). For staining of actin
fibers, cell were incubated with Alexa Fluor 488 phalloidin (Invitrogen, A12379), which was added at
the secondary antibody incubation step at a 1:1000 dilution. All the steps were carried out at room
temperature. Images were acquired from a fluorescence microscope (Zeiss Ax10, 40X) attached to
CCD AxioCam and analyzed on AxioVision (v4.8.2).
Image analysis
All the imaging analyses were carried out using the ImageJ free software (https://imagej.nih.gov/ij/
download.html). To calculate the actin anisotropy, the FibrilTool plugin in ImageJ was used
(Boudaoud et al., 2014). Phalloidin stained images were divided into four regions of interest and
analysis performed for each area. To calculate nucleus size, DAPI stained images were analyzed
using the following ImageJ commands: Adjust color threshold/Make Binary/Analyze Particles. The
area values (Pixels) and count of nucleus in the field were then obtained for each field. To calculate
the average of the cell size, first the fraction of the field occupied by the ACTIN staining was calcu-
lated using ImageJ (Adjust color threshold/Make Binary/Measure). The percentage of the area of
ACTIN staining was divided by the number of cells in the respective field to obtain the average of
the cell size. Statistical significance was tested using Mann-Whitney-Wilcoxon Test (*p<0.05,
**p<0.01, ***p<0.001). Statistical analyses and data visualization were carried out in RStudio (http://
www.rstudio.com/).
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RNAseq analyses
Total RNA from three biological replicates of RBPMS knockdown in differentiated PAC1 and three
populations of RBPMS inducible overexpression in proliferative PAC1 cells were extracted for RNA-
seq. Cells were lysed with TRI-reagent and total RNA purified by Direct-zol purification column
(Zymo Research) followed by DNase treatment. RNAseq libraries of polyA selected RNAs were pre-
pared with NEBNext ultra II RNA library prep kit for Illumina. Both RNA and RNAseq libraries were
checked for their qualities. Barcoded RNAseq libraries were then multiplexed across two lanes of an
Illumina HiSeq4000 platform for sequencing on a 150 bp paired-end mode, providing around 60 mil-
lion reads per sample.
To investigate AS changes in vascular smooth muscle dedifferentiation, rat aortas were isolated
from 8 to 12 weeks old Wistar rats. Aortas were briefly treated for 30 min at 37˚C with 3 mg/ml colla-
genase (Sigma C-0130) to help in cleaning away the adventitia. The tissue was finely chopped and
either used directly to make tissue RNA or enzymatically dispersed to single cells. This was achieved
by treating the tissue pieces with 5 ml 1 mg/ml elastase (Worthington Biochemical Corporation
LS002292) for 30 min at 37˚C and then 5 ml collagenase added for a further 1–2 hr. Cells were
washed and counted and plated at 4  105 cells/ml in M199 media containing 10%FBS, 2 mM Gluta-
mine and 100 U/ml Penicillin-Streptomycin in a suitable dish according to the cell number. To pro-
mote the proliferative state, SMCs were 1:2 passaged switching to DMEM media containing
Glutamax and 10% FBS and harvested at passage 9. For RNAseq, total RNA was harvested from
three replicas, each a pool of 5 rats, from rat aorta tissue (T), enzymatically dispersed single cultured
SMCs (SC), passage 0 (P0) and passage 9 (P9). Total RNA extraction was carried out with Tri-reagent
(Sigma). Libraries for mRNAseq were prepared using Ribozero and TrueSeq kits and sequencing per-
formed on a HiSeq2000 platform in a paired-end mode.
mRNA abundance analysis
Read trimming and adapter removal were performed using Trimmomatic version 0.36 (Bolger et al.,
2014). Reads were aligned using STAR version 2.5.2a (Dobin et al., 2013) to the Rat genome
Rnor_6.0 release-89 obtained from Ensembl and RSEM package version 1.2.31 (Li and Dewey,
2011) was used to obtain gene level counts. mRNA abundance analysis, was carried out with
DESeq2 package (version 1.18.1) (Love et al., 2014) within R version 3.4.1 (https://www.r-project.
org/). Genes were considered to be differential expressed with p-adj less than 0.05 in the paired
analysis (Supplementary file 2).
AS analysis
rMATS v3.2.5 (Shen et al., 2014) was used for detection of differential alternative splicing. rMATS
analysis was carried out allowing for new splicing event discovery using the flag novelSS 1. rMATS
calculates the inclusion levels of the alternative spliced exons and classifies them into five categories
of AS events (Figure 2—figure supplement 1B): skipped exons (SE), mutually exclusive exons
(MXE), alternative 5’ and 3’ splice sites (A5SS and A3SS) and retained intron (RI). Before further anal-
ysis, the results from reads on target and junction counts were filtered to include only events with a
total of read counts above 50 across the triplicates in at least one of the conditions compared.
Removal of events with low counts discarded false positive events. Only ASE with an FDR less than
0.05 were considered significant and a minimal inclusion level difference of 10% imposed to signifi-
cant AS events. Finally, to identify specific AS events, unique IDs were created using the AS type,
gene name and the chromosomal coordinates of the regulated and flanking exons
(Supplementary file 3).
For visualization of differentially spliced exons, sashimi plots were generated using rmats2sashimi-
plot (Gohr and Irimia, 2019). The sashimi plots show the RNAseq coverage reads mapping to the
exon-exon junctions and PSI values from rMATS. Twenty eight ASE identified by rMATS in the
RBPMS knockdown or overexpression were also validated by RT-PCR in the same manner as
described in the qRT-PCR and RT-PCR section. DPSI predicted from the RNAseq analysis and the
DPSI observed in the RT-PCR were then tested for a Pearson correlation in RStudio (http://www.rstu-
dio.com/).
For comparison and visualization of the overlap between the genes with different mRNA abun-
dance and the genes differentially spliced in the RBPMS knockdown, RBPMS overexpression and the
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PAC1 dedifferentiation, proportional Venn diagrams were made using BioVenn (Hulsen et al.,
2008). Venn diagrams were also generated for the visualization of the common AS events across
RBPMS knockdown, overexpression and the PAC1 or aorta tissue dedifferentiation datasets.
RBPMS motif enrichment analysis
RBPMS motif enrichment analyses in the regulated cassette exons (SE) of RBPMS knockdown and
overexpression, PAC1 and Aorta tissue dedifferentiation were performed using the toolkit MATT
(Gohr and Irimia, 2019). Cassette exons in transcripts identified by rMATS with significant changes
(FDR < 0.05 and |DPSI| > 10%) were used to test enrichment or depletion of CACN1-12CAC RBPMS
recognition element (Farazi et al., 2014), against a background set of unregulated exons defined as
events with FDR > 0.1 and |DPSI| < 5%. 250 bp of the flanking intronic regions were examined for
RBPMS motif signals. The motif enrichment scores were first obtained using the test_regexp_enrich
command of the Matt suite in the quant mode with statistical significance determined using a per-
mutation test with 50,000 iterations. This module inherently divides the examined regions (exons or
250 bp of the introns) into thirds and provides positional information for the occurrence of the
RBPMS motif.
RNA maps for distribution of the RBPMS motif were generated using the rna_maps command in
the Matt suite. Here the unregulated set of exons was randomly downsampled to include a final
background of 2000 events only. Additionally, the program was instructed to scan only 135 bp of
the cassette exon and 250 bp at either end of the flanking introns. A sliding window of 31 was used
for scanning the motif and the statistically significant regions (p<0.05) for enrichment or depletion
were identified by the permutation tests specifying 1000 iterations.
Gene ontology and PPI analysis
Enrichment for gene ontology terms in the differentially abundant and spliced genes were obtained
from Gorilla (Eden et al., 2009). Two unranked lists of genes, target and background lists, were
used for the GO analysis. The target list contained either the significant differential abundant genes
(p-adj <0.05 and log2 Fold Change greater than one or less than  1) or the significant differentially
spliced genes (FDR < 0.05 and DPSI threshold of 10%). Background gene lists were created for the
PAC1 experiments and aorta tissue by selecting the genes whose expression were higher than 1
TPM in either of the conditions analyzed. For visualization, only the top five enriched GO terms of
each category (biological process, cell component and molecular function) were shown in Figure 5A
and Figure 5—figure supplement 1. The complete list of enriched terms in differentially spliced
and abundant genes can be found in Supplementary files 4 and 5.
A Protein-protein interaction network for the genes differentially spliced by RBPMS was con-
structed using the STRING v10.5 database (Szklarczyk et al., 2017). RBPMS-regulated genes were
obtained by merging two lists: i) overlap of genes concordantly differentially spliced in the RBPMS
knockdown and PAC1 experiments and, ii) overlap of genes concordantly differentially spliced in the
RBPMSA overexpression and the aorta tissue datasets that were shown to be regulated in the same
range in both conditions. A cut off of DPSI greater than 10% was also applied to the RBPMS-regu-
lated gene list, similar to the GO analysis. The human database was chosen for the analysis and the
following parameters applied to the PPI network: confidence as the meaning of the network edges,
experiments and database as the interaction sources and high confidence (0.700) as the minimum
required interaction score. STRING functional enrichments, using the whole genome as statistical
background, were also included for visualization. Human super-enhancer associated genes from
Supplementary file 1 were highlighted.
Recombinant protein
Rat RBPMS A and B with a 3xFLAG N terminal tag were cloned into the BamHI/XhoI sites of the
expression vector pET21d, for expression of recombinant RBPMS containing a T7 N-terminal tag
and a His6 C-terminal tag in E. coli. Recombinant RBPMS A protein was purified using Blue Sephar-
ose six and HisTrap HP columns whereas RBPMS B was purified only through the latter, since low
binding was observed to Blue Sepharose 6. The identity of purified recombinant proteins was con-
firmed by western blot (Figure 4—figure supplement 4) and mass mapping by mass spectrometry.
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In vitro transcription and binding
a32P-UTP labelled RNA probes were in vitro transcribed using SP6 RNA polymerase. For EMSAs, a
titration of the recombinant RBPMS A and B (0, 0.125, 0.5 and 2 mM) was incubated with 10 fmol of
in vitro transcribed RNA in binding buffer (10 mM Hepes pH 7.2, 3 mM MgCl2, 5% glycerol, 1 mM
DTT, 40 mM KCl) for 25 min at 30˚C. After incubation, samples were run on a 4% polyacrylamide
gel. For UV-crosslinking experiments, the same binding incubation was performed followed by UV-
crosslink on ice in a Stratalinker with 1920 mJ. Binding reactions were then incubated with RNase A1
and T1 at 0.28 mg/ml and 0.8 U/ml respectively, for 10 min at 37˚C. Prior to loading the samples
into a 20% denaturing polyacrylamide gel, SDS buffer was added to the samples which were then
heated for 5 min at 90˚C.
Statistical analysis
Analysis and quantification of RNAseq, RT-PCR and imaging experiments were described in their
respective sections with further information of the tests used in the different experiments present in
the figure legends. Graphics were generated in RStudio (http://www.rstudio.com/).
Data availability
mRNAseq of RBPMS (knockdown and overexpression) and Aorta tissue dedifferentiation data from
this study have been deposited in NCBI Gene Expression Omnibus (GEO) repository under GEO
accession GSE127800, accession number GSE127799 and GSE127794, respectively.
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